Lepu ScienTech Medical Technology (Shanghai) (HKG:2291) said controlling shareholder Lepu Medical Technology (Beijing) (SHE:300003) sold 11.14 million H-shares through a block trade on Tuesday, according to a same-day Hong Kong bourse filing.
The shares were placed at HK$22.79 each, representing about 3.2% of the company's issued share capital.
Following the sale, Lepu Medical still holds roughly 268.86 million shares, or 77.5% of Lepu ScienTech, including stakes via its subsidiary Beijing Target Medical Technologies.
The company said the disposal was aimed at improving share liquidity and will not affect its operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments